ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Seer Inc

Seer Inc (SEER)

2.26
0.02
(0.89%)
Al cierre: 12 Noviembre 3:00PM
2.2201
-0.0399
( -1.77% )
Fuera de horario: 4:44PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
2.2201
Postura de Compra
2.22
Postura de Venta
2.33
Volume Operado de la Acción
264,164
2.18 Rango del Día 2.28
1.455 Rango de 52 semanas 2.4599
Capitalización de Mercado [m]
Precio Anterior
2.24
Precio de Apertura
2.20
Última hora de negociación
16:44:39
Volumen financiero
US$ 589,715
Precio Promedio Ponderado
2.2324
Volumen promedio (3 m)
289,100
Acciones en circulación
58,966,560
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.54
Beneficio por acción (BPA)
-1.46
turnover
16.66M
Beneficio neto
-86.28M

Acerca de Seer Inc

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Mostrar más

Sector
Lab Analytical Instruments
Industria
Lab Analytical Instruments
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was US$2.24. Over the last year, Seer shares have traded in a share price range of US$ 1.455 to US$ 2.4599.

Seer currently has 58,966,560 shares in issue. The market capitalisation of Seer is US$132.09 million. Seer has a price to earnings ratio (PE ratio) of -1.54.

SEER Últimas noticias

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.210110.45273631842.012.459924316542.21751949CS
40.240112.12626262631.982.45991.822189112.07314481CS
120.570134.55151515151.652.45991.5852891001.84492948CS
260.220111.00522.45991.564271611.81476667CS
520.640140.51265822781.582.45991.4554554851.80819936CS
156-27.1199-92.433197000729.3431.83151.4553966936.26816914CS
260-45.7799-95.37479166674886.551.45541861216.82388339CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MVSTMicrovast Holdings Inc
US$ 0.2999
(65.97%)
8.82M
NMHINatures Miracle Holding Inc
US$ 0.1135
(32.44%)
7.81M
DAVEDave Inc
US$ 79.17
(26.07%)
45.59k
RKLBRocket Lab USA Inc
US$ 18.1001
(23.47%)
7.54M
ONMDOneMedNet Corporation
US$ 1.16
(22.11%)
5.45M
SYRSSyros Pharmaceuticals Inc
US$ 0.3845
(-85.92%)
9.25M
VINOGaucho Group Holdings Inc
US$ 2.32
(-47.87%)
173.73k
VRMVroom Inc
US$ 5.50
(-37.99%)
47.71k
SIBNSI BONE Inc
US$ 11.50
(-26.42%)
4.8k
INSGInseego Corporation
US$ 13.69
(-24.61%)
36.64k
JGLOJP Morgan Global Select Equity ETF
US$ 63.13
(0.00%)
18.88M
SOUNSoundHound AI Inc
US$ 6.86
(-9.26%)
12.88M
LGMKLogicMark Inc
US$ 0.1764
(-1.18%)
9.72M
SYRSSyros Pharmaceuticals Inc
US$ 0.3845
(-85.92%)
9.25M
MVSTMicrovast Holdings Inc
US$ 0.2999
(65.97%)
8.83M
MartinLutherKing MartinLutherKing 3 minutos hace
News tomorrow morning brother…
ELAB
MysticalRaider80 MysticalRaider80 3 minutos hace
Activity today we going to see big volume very soon mark my word
HFBG
SuperLogisticsMan SuperLogisticsMan 4 minutos hace
Q3 financials are due November 14. Last quarter they reported a day early. We might see financials late tomorrow.
CYBL
norisknorewards norisknorewards 4 minutos hace
And what PR that only moves the price to .37c would they PR tomorrow given their obvious desire to keep info close to the chest...

Nonsense
NWBO
BamaBreeze BamaBreeze 4 minutos hace
Hope your wrong. Have a wonderful 
Holiday season!!! Maybe some of the joy will infiltrate your bones!!!
BLLB
manibiotech manibiotech 5 minutos hace
I hope you are right . But there was no immediate plan for revenue . No definitive partnerships /JVs with upfront capital . Continuing dilution. Approval happens when it happens and doesn't look imminent in my opinion .  No concrete plans for FDA that I could see . 
I think those are the thin
NWBO
ironhammer ironhammer 5 minutos hace
and when we do get gold many will be chasing
NBRI
StockInfo11 StockInfo11 5 minutos hace
Today, OCG.v shared that regional exploration at its Santa Ana Project shows strong potential for resource growth along its 17km permitted vein corridor. Highlights include high-grade silver assays up to 1,737 g/t & gold assays up to 53.92 g/t. Ongoing drilling & mapping aim for near-term expansion.
OCGSF
SuperLogisticsMan SuperLogisticsMan 5 minutos hace
Yeah...OK...whatever you say. In the meantime....

https://www.msn.com/en-us/news/world/ukrainian-drones-decimate-russian-tankers-in-kursk-counter/vi-AA1tWVR5?ocid=msedgntp&pc=DCTS&cvid=2e66847572854f638692fdcc5a2ca772&ei=19#
CYBL
shajandr shajandr 6 minutos hace
On watch for blowoff topp. In other news,is this called 'hitting for the cycle" in the pennyscam world?

https://investorshub.advfn.com/uimage/uploads/2024/11/12/ujexzhiph.JPG

Ticker is HIPH, an old Alfie Culbertson bottled water scam. Now owned by a Chinese guy who has
bigsur25 bigsur25 6 minutos hace
56 days
MONI
StockInfo11 StockInfo11 6 minutos hace
Borealis Mining (BOGO.v) is advancing its fully owned Borealis gold project in Nevada's Walker Lane Gold Trend, aiming for 100K oz/year production. The project features a significant resource base of 1.83 Moz at 1.28 g/t Au (M&I) and 195,000 oz at 0.34 g/t Au (inferred). Ongoing high-grade drilling
BOGO
jour_trader jour_trader 6 minutos hace
If this is due to earnings, they aren't released until after close Thursday. Unless you are seeing a Vyvanse approval this week nothing would shoot it up that high. 
ELTP
wadegarret wadegarret 6 minutos hace
KINS eps guidance was in basic share count, not

fully diluted. To get to fully diluted, you must take about 20% off. So if $1.80/basic share is the average eps guided for in 2025, then $1.44 is about right for fully diluted. I believe KINS is worth at most a 10 PE going forward on f
richme richme 6 minutos hace
No. It was LAHO.
ZHUD
glenn1919 glenn1919 6 minutos hace
MVST.......................https://stockcharts.com/h-sc/ui?s=MVST&p=W&b=5&g=0&id=p86431144783
MVST
MartinLutherKing MartinLutherKing 7 minutos hace
Real deal Hollyfield brothers https://quantisnow.com/insight/elevai-labs-forms-new-scientific-advisory-board-for-its-weight-loss-programs-5558017
ELAB
WHELANer WHELANer 7 minutos hace
I’m good looper. Why’d ya block me ? Any hope or is Kelly a scammer like her old man ?
NKE
RickNagra RickNagra 7 minutos hace
Happy anniversary everyone.
https://x.com/ricknagra/status/1856483446001934502?s=46&t=xLP2LlWgJrEMUZZ7Fum-nA

FNMA
nyt nyt 7 minutos hace
https://youtu.be/8_mePjkQW_c?si=mn_0JMNVC4JMQdKL
VPLM
Mister Mr Mister Mr 7 minutos hace
I hope not!
SAPX
santafe2 santafe2 7 minutos hace
Kakistocracy is fine but I prefer the modern interpretation: Idiocracy.

Su Consulta Reciente

Delayed Upgrade Clock